JP2024510504A5 - - Google Patents

Info

Publication number
JP2024510504A5
JP2024510504A5 JP2023557370A JP2023557370A JP2024510504A5 JP 2024510504 A5 JP2024510504 A5 JP 2024510504A5 JP 2023557370 A JP2023557370 A JP 2023557370A JP 2023557370 A JP2023557370 A JP 2023557370A JP 2024510504 A5 JP2024510504 A5 JP 2024510504A5
Authority
JP
Japan
Application number
JP2023557370A
Other languages
Japanese (ja)
Other versions
JP2024510504A (ja
JPWO2022197789A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/020527 external-priority patent/WO2022197789A1/en
Publication of JP2024510504A publication Critical patent/JP2024510504A/ja
Publication of JPWO2022197789A5 publication Critical patent/JPWO2022197789A5/ja
Publication of JP2024510504A5 publication Critical patent/JP2024510504A5/ja
Pending legal-status Critical Current

Links

JP2023557370A 2021-03-17 2022-03-16 血漿カリクレインの多環式インヒビター Pending JP2024510504A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163162483P 2021-03-17 2021-03-17
US63/162,483 2021-03-17
PCT/US2022/020527 WO2022197789A1 (en) 2021-03-17 2022-03-16 Polycyclic inhibitors of plasma kallikrein

Publications (3)

Publication Number Publication Date
JP2024510504A JP2024510504A (ja) 2024-03-07
JPWO2022197789A5 JPWO2022197789A5 (https=) 2025-03-25
JP2024510504A5 true JP2024510504A5 (https=) 2025-03-25

Family

ID=81328648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557370A Pending JP2024510504A (ja) 2021-03-17 2022-03-16 血漿カリクレインの多環式インヒビター

Country Status (5)

Country Link
US (1) US20240199613A1 (https=)
EP (1) EP4308564A1 (https=)
JP (1) JP2024510504A (https=)
CN (1) CN117355523A (https=)
WO (1) WO2022197789A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200143376A (ko) 2018-03-13 2020-12-23 샤이어 휴먼 지네틱 테라피즈 인크. 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도
CN114667289B (zh) 2019-09-18 2025-08-26 武田药品工业有限公司 杂芳基血浆激肽释放酶抑制剂
EP4031547B1 (en) 2019-09-18 2024-07-17 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof
CN118239959A (zh) * 2022-12-23 2024-06-25 上海深势唯思科技有限责任公司 环丙烷类tlr7和8抑制剂及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
ATE141502T1 (de) 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
NZ526472A (en) * 2000-12-21 2004-04-30 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors
CA2569406A1 (en) * 2004-06-04 2005-12-22 Icos Corporation Methods for treating mast cell disorders
KR20080080584A (ko) * 2005-11-30 2008-09-04 버텍스 파마슈티칼스 인코포레이티드 c-Met의 억제제 및 이의 용도
WO2013052526A1 (en) * 2011-10-06 2013-04-11 Merck Sharp & Dohme Corp. Triazolyl pde10 inhibitors
JP6280546B2 (ja) * 2012-06-26 2018-02-14 デル マー ファーマシューティカルズ ジアンヒドロガラクチトール、ジアセチルジアンヒドロガラクチトール、ジブロモズルシトール、又はこれらの類似体若しくは誘導体を用いた、遺伝子多型又はahi1の調節不全若しくは変異を有する患者におけるチロシンキナーゼインヒビター抵抗性悪性腫瘍を処置するための方法
CN104059069B (zh) * 2013-08-22 2016-08-10 北京康立生医药技术开发有限公司 一种替卡格雷的制备方法
WO2015164308A1 (en) * 2014-04-22 2015-10-29 Merck Sharp & Dohme Corp. FACTOR XIa INHIBITORS
KR20200143376A (ko) 2018-03-13 2020-12-23 샤이어 휴먼 지네틱 테라피즈 인크. 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2024510504A5 (https=)
CL2025002731A1 (es) Manipulación microfluídica de muestras
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13174U (https=)
BY13167U (https=)
CN307047751S (https=)
CN307047636S (https=)
CN307046290S (https=)
CN307045634S (https=)
CN307044962S (https=)
CN307049072S (https=)
CN307044302S (https=)
BY13135U (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
CN307044670S (https=)
BY13140U (https=)